|






|
 |
The following information is from
www.myelomaonline.org.uk
How your myeloma is managed will depend on whether the myeloma
is getting worse and the degree to which it has affected your
body.
Up until the last few years, the most commonly used treatments
for myeloma were different kinds of chemotherapy, steroids,
high-dose therapy and stem cell transplantation. Recently, however,
two new treatments have been introduced into the range of drugs
available: thalidomide and bortezomib (VELCADE) (an analogue
of thalidomide called lenalidomide (REVLIMID)should be available
soon).
There are also a number of supportive treatments to help treat
the symptoms and complications that myeloma can cause. These
include a group of drugs called bisphosphonates used to treat
bone disease and bone pain as well as erythropoietin for anaemia.
Before embarking on treatment, however, patients and doctors
need to make important decisions about what treatment is best
or most appropriate and when to receive it.
This section looks at some important points in making treatment
decisions and provides a brief overview of the range of treatments
available to treat both the underlying problem and the complications
and symptoms due to myeloma.
Choosing treatment for myeloma is not a simple decision as
no one treatment has been identified as being the best, and
all patients are different.
The advantages, disadvantages and side effects arising from
available treatments are often quite different. For this reason,
being involved in deciding which treatment is right for you
is very important.
You may prefer just to follow the advice of your doctor or
to take a more active role in the decision-making process.
Your doctor should be able to adapt his or her approach accordingly
to suit you.
Generally, the best treatment for you will take account of:
- Your general health (for example,
your kidney function)
- Your age (for example, it may
affect whether high-dose therapy and stem cell transplantation
is possible)
- Your personal circumstances and
lifestyle
- Your priorities and preferences
- The nature of your disease
- Any previous treatments
- Level of complications
- Results and response to any previous
treatment received
Making an informed decision is important and you should take
as much time as you need to make one. However, in some situations
there may be an urgent need to start treatment, for example,
if you have significant kidney damage.
To help you understand more about your myeloma and the treatment
options available, try to collect as much information as you
feel you need. Information is available from doctors, nurses,
other patients, websites and Myeloma UK.
Listing the pros and cons of each option is a good way to
help you decide what the best treatment for you is. Talking
things over with your family, friends or another patient can
help clarify your thoughts.
Your decision should take into account your personal priorities,
your lifestyle and how you feel about the pros and cons of
the treatment options that are available and their potential
side effects. The important thing is that you and your doctor
agree together on the treatment you will receive.

The way cancer services are currently organised in the UK
means that the hospital where you are being treated should
involve a range of healthcare professionals working together
as a team known as a multidisciplinary team.
Your treatment is likely to have been discussed by the team,
although often only one doctor (usually the consultant haematologist)
will look after you.
Because myeloma is not common, and choosing the right treatment
is sometimes as challenging for doctors as it is for patients,
you may feel that you want a second opinion to be sure that
the diagnosis is correct, that the treatment plan is appropriate
for your situation and that all other options have been considered.
Doctors are normally happy to arrange a second opinion and
you should not feel that asking for one will offend him or
the medical team. Your hospital doctor or GP can organise
an appointment for you with another doctor (usually another
consultant haematologist).
A second opinion can be obtained through the NHS, although
some people prefer to go privately. Your notes will be passed
on to the second doctor before your visit so they are familiar
with your particular situation.
Sometimes people have difficulty in communicating with their
doctor and want the chance to talk to another doctor. In this
circumstance, you may ask to see a different doctor in the
same hospital or to have a second opinion at another hospital.

Some patients feel that they do not want to have any type
of toxic treatment and prefer to try an alternative approach
such as dietary control, etc. Unfortunately, there is no evidence
that these alternative approaches work, although very occasionally
patients report that by using these techniques they have lived
with the disease for many years longer than was predicted.
It is important to remember that conventional treatments have
been well tested in clinical studies and doctors have a clear
understanding of how they work. The same cannot be said for
alternative approaches. If you choose to use alternative ways
of trying to control your disease, it is important to discuss
this with your doctor as there are potential risks involved
and you may choose to try conventional treatment at a later
date.
If you choose not to have active treatment for your myeloma
there are many supportive measures available, as outlined
earlier, to help alleviate the symptoms of your disease.
If specialist advice is needed with regard to symptoms such
as pain, it may be helpful to be seen by a palliative care
specialist, who will be able to provide expertise in symptom
control and supportive care.

The decision to start or not to start treatment is an important
one. Not everyone diagnosed with myeloma will need treatment
to control his or her myeloma immediately.
Because currently available treatment is not curative and has
side effects it is usual to wait until the myeloma is actively
causing problems before starting treatment. Results from the
tests and investigations listed earlier, along with other individual
factors, will help determine when treatment should begin, what
that treatment should be and provide a baseline against which
response to treatment and disease progression can be measured.
Please Note:For the most up to date reports on current treatments,
clinical trials and cutting adge research please refer to:

All information available on this or any other site mentioned
in this site should not be relied upon as complete or accurate,
nor should it be relied on to suggest a course of treatment
for a particular individual. It should not be used in place
of a visit, call, consultation or the advice of a licensed physician
or other qualified health care provider. Patients with health
care related questions orconcerns are advised to contact a physician
or other qualified healthcare provider promptly.
|
 |
|
|
|